Also trades as: ESLA (NASDAQ) · $vol 0M
ESLAW NASDAQ
Estrella Immunopharma, Inc.
1W: -1.0%
1M: -51.4%
3M: -11.7%
YTD: -26.4%
1Y: -4.1%
$0.07
+0.01 (+10.33%)
Weekly Expected Move ±44.8%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
19 relationships19
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2021-07-19
Earliest Filing
2024-12-06
Latest Filing
investor: 8
partner: 7
target: 4
Counterparties (Filed by ESLAW)
19 relationshipsCompanies named in ESLAW's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| White Lion Capital, LLC | — | investor | Amendment to Common Stock Purchase Agreement allowing Estrella Immunopharma to sell up to $50 million of common stock to | 2024-12-06 | View |
| Cofame Investment Management Co. Ltd. | — | partner | Consulting agreement for advisory services with upfront payment and annual fee | 2024-11-07 | View |
| Eureka Therapeutics, Inc. | — | partner | Services provider for Estrella's clinical trial under Statement of Work and Services Agreement | 2024-05-13 | View |
| Estrella Biopharma, Inc. | — | partner | Wholly-owned subsidiary of Estrella Immunopharma, Inc. entering into a Statement of Work for clinical trial services. | 2024-03-07 | View |
| Eureka Therapeutics, Inc. | — | partner | Controlling shareholder of Estrella Immunopharma, Inc. and provider of clinical trial services under a Statement of Work | 2024-03-07 | View |
| Plentiful Limited | — | investor | Investor in PIPE subscription agreement | 2023-09-20 | View |
| Lianhe World Limited | — | investor | Investor in PIPE subscription agreement | 2023-09-20 | View |
| Estrella Biopharma, Inc. | — | target | Target company in proposed Business Combination | 2023-09-20 | View |
| Suma Ventures, LLC | — | investor | Investor entering binding term sheet for PIPE investment and debt waiver in Business Combination | 2023-07-26 | View |
| Estrella Biopharma, Inc. | ESLA | target | Target company in proposed Business Combination with TradeUP Acquisition Corp. | 2023-07-26 | View |
| Eureka Therapeutics, Inc. | — | partner | Partner company involved in proposed Business Combination and holding payables owed by Estrella | 2023-07-26 | View |
| White Lion Capital, LLC | — | investor | Received 250,000 shares of Estrella's Series A preferred stock as part of an amendment to the common stock purchase agre | 2023-04-26 | View |
| Estrella Biopharma, Inc. | — | target | Target company in the proposed business combination with TradeUP Acquisition Corp. | 2023-04-26 | View |
| White Lion Capital, LLC | — | investor | Agreed to purchase up to $50M in common stock and receive Estrella Series A Preferred Stock as a commitment fee. | 2023-04-24 | View |
| Estrella Biopharma, Inc. | — | partner | Target company in the proposed business combination and issuer of Series A Preferred Stock to White Lion. | 2023-04-24 | View |
| Estrella Biopharma, Inc. | — | target | Target company in a merger agreement with TradeUP Acquisition Corp. | 2022-10-03 | View |
| TradeUP Acquisition Sponsor LLC | — | investor | Sponsor and founder purchasing private placement shares | 2021-07-19 | View |
| Tradeup INC. | — | investor | Founder purchasing private placement shares | 2021-07-19 | View |
| VStock Transfer, LLC | — | partner | Warrant agent | 2021-07-19 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-08 | Delisting Notice | View | |
| 2026-08-21 | Delisting Notice | View | |
| 2026-06-30 | Shareholder Vote | View | |
| 2026-01-13 | Notice of Delisting or Transfer | View | |
| 2026-01-06 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Dis | Agreement | View |
| 2025-12-04 | Other Events; Financial Statements and Exhibits | View | |
| 2025-11-06 | Other Events; Financial Statements and Exhibits | View | |
| 2025-09-29 | Other Events | View | |
| 2025-09-26 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-08-07 | Notice of Delisting or Transfer | View | |
| 2025-06-05 | Other Events; Financial Statements and Exhibits | View | |
| 2025-06-03 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Other Events; Fin | Agreement | View |
| 2025-05-29 | Other Events; Financial Statements and Exhibits | View | |
| 2025-05-02 | Notice of Delisting or Transfer | View | |
| 2025-02-21 | Other Events; Financial Statements and Exhibits | View | |
| 2025-02-20 | Other Events; Financial Statements and Exhibits | View | |
| 2024-12-16 | Other Events | View | |
| 2024-12-06 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2024-11-26 | Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits | View | |
| 2024-11-25 | Notice of Delisting or Transfer | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR